EFFECTS OF CYP2C9☆13 ALLELE ON THE PHARMACOKINETICS OF IRBESARTAN

被引：0
|
作者：
Park, J., I [1 ]
Choi, C., I [1 ]
Bae, J. W. [1 ]
Jang, C. G. [1 ]
Lee, S. Y. [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Pharm, Seoul, South Korea
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2011年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：64 / 64
页数：1
相关论文
共 50 条
  • [1] Effects of CYP2C9*13 allele on the pharmacokinetics of Irbesartan
    Lim, Hye-Jin
    Kim, Dong-Hyun
    Byeon, Ji-Yeong
    Kim, Young-Hoon
    Kim, Se-Hyung
    PHARMACOTHERAPY, 2015, 35 (11): : E315 - E316
  • [2] Effects of the CYP2C9*13 allele on the pharmacokinetics of losartan in healthy male subjects
    Li, Z.
    Wang, G.
    Wang, L. -S.
    Zhang, W.
    Tan, Z. -R.
    Fan, L.
    Chen, B. -L.
    Li, Q.
    Liu, J.
    Tu, J. -H.
    Hu, D. -L.
    Liu, Z. -Q.
    Zhou, H. -H.
    XENOBIOTICA, 2009, 39 (10) : 788 - 793
  • [3] Effects of CYP2C9 polymorphism on the pharmacokinetics of irbesartan in healthy Korean subjects
    Kim, Mi-Jung
    Bae, Jung -Woo
    Han, Ho-Kyun
    Choi, Sun-Ok
    Kim, Ok-Hee
    Jang, Choon-Gon
    Lee, Jin-Hee
    Kim, Nam-Tae
    Lee, Seok-Yong
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 231 - 231
  • [4] Effects of CYP2C9*1/*13 on the pharmacokinetics and pharmacodynamics of meloxicam
    Bae, Jung-Woo
    Choi, Chang-Ik
    Jang, Choon-Gon
    Lee, Seok-Yong
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 71 (04) : 550 - 555
  • [5] Effects of the CYP2C9*1/*13 Genotype on the Pharmacokinetics of Lornoxicam
    Choi, Chang-Ik
    Kim, Mi-Jeong
    Jang, Choon-Gon
    Park, Young-Seo
    Bae, Jung-Woo
    Lee, Seok-Yong
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 (06) : 476 - 480
  • [6] CYP2C9*3 and *13 alleles significantly affect the pharmacokinetics of irbesartan in healthy Korean subjects
    Chang-Ik Choi
    Mi-Jeong Kim
    Eun-Kyung Chung
    Hye-In Lee
    Choon-Gon Jang
    Jung-Woo Bae
    Seok-Yong Lee
    European Journal of Clinical Pharmacology, 2012, 68 : 149 - 154
  • [7] CYP2C9*3 and *13 alleles significantly affect the pharmacokinetics of irbesartan in healthy Korean subjects
    Choi, Chang-Ik
    Kim, Mi-Jeong
    Chung, Eun-Kyung
    Lee, Hye-In
    Jang, Choon-Gon
    Bae, Jung-Woo
    Lee, Seok-Yong
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (02) : 149 - 154
  • [8] Effects of CYP2C9*3 and CYP2C9*13 alleles on the pharmacokinetics of celecoxib and its carboxylic metabolite.
    Park, So-Young
    Lee, Hye-In
    Choi, Chang-Ik
    PHARMACOTHERAPY, 2012, 32 (10): : E235 - E235
  • [9] Lack of differences in diclofenac (a substrate for CYP2C9) pharmacokinetics in healthy volunteers with respect to the single CYP2C9*3 allele
    Shimamoto, J
    Ieiri, I
    Urae, A
    Kimura, M
    Irie, S
    Kubota, T
    Chiba, K
    Ishizaki, T
    Otsubo, K
    Higuchi, S
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 56 (01) : 65 - 68
  • [10] Distribution of CYP2C9*13 allele in the Chinese Han and the long-range haplotype containing CYP2C9*13 and CYP2C19*2
    Si, Dayong
    Wang, Juan
    Zhang, Yifan
    Zhong, Dafang
    Zhou, Hui
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2012, 33 (06) : 342 - 345
12345